-
-
-
-
-
-
-
TransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
-
-
-
-
-
-
-
TransCode Therapeutics Announces Equity Investment from White Lion Capital to Help Fund Development of TTX-MC138 for Treatment of Glioblastomas
-
-
-
-
-
-
-
TransCode Therapeutics Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
-
70,673 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

